Target
Adenosine receptor A3 [I248L]
Ligand
BDBM50310922
Substrate
n/a
Meas. Tech.
Fluorometric Imaging Plate Reader (FLIPR) Asssay
IC50
233.1±n/a nM
Citation
 Jordan, ABedford, SBurkhard, KYule, IPoullennec, K Thienopyrimidine compounds US Patent  US9120807 Publication Date 9/1/2015 
Target
Name:
Adenosine receptor A3 [I248L]
Synonyms:
AA3R_HUMAN | ADORA3 | Adenosine receptor A3 | Adenosine receptor A3 (A3)
Type:
Protein
Mol. Mass.:
36197.32
Organism:
Homo sapiens (Human)
Description:
P0DMS8[I248L]
Residue:
318
Sequence:
MPNNSTALSLANVTYITMEIFIGLCAIVGNVLVICVVKLNPSLQTTTFYFIVSLALADIAVGVLVMPLAIVVSLGITIHFYSCLFMTCLLLIFTHASIMSLLAIAVDRYLRVKLTVRYKRVTTHRRIWLALGLCWLVSFLVGLTPMFGWNMKLTSEYHRNVTFLSCQFVSVMRMDYMVYFSFLTWIFIPLVVMCAIYLDIFYIIRNKLSLNLSNSKETGAFYGREFKTAKSLFLVLFLFALSWLPLSLINCIIYFNGEVPQLVLYMGILLSHANSMMNPIVYAYKIKKFKETYLLILKACVVCHPSDSLDTSIEKNSE
  
Inhibitor
Name:
BDBM50310922
Synonyms:
CHEMBL1080241 | US9120807, 9 | {6-Amino-2-[(pyridin-3-ylmethyl)-amino]-thieno[3,2-d]pyrimidin-4-yl}-thiophen-2-yl-methanone
Type:
Small organic molecule
Emp. Form.:
C17H13N5OS2
Mol. Mass.:
367.448
SMILES:
Nc1cc2nc(NCc3cccnc3)nc(C(=O)c3cccs3)c2s1
Structure:
Search PDB for entries with ligand similarity: